200x28 colored logo_LP.png

Using Real-World Evidence to Accelerate Drug Approvals for Rare Diseases

The first-line therapy indication for metastic Merkel cell carcinoma (mMCC) was completed using real-world data and insights1 to gain the first-ever FDA approval for this rare disease.

Using Real-World Evidence to Accelerate Drug Approvals for Rare Diseases

Please fill out the form to download the Case Study: